Ferumoxytol vs iron sucrose for child kidney anemia
Treatments studied
Part of Blood & lymphatic, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study compares two IV iron treatments—ferumoxytol and iron sucrose—to treat iron deficiency anemia in children with chronic kidney disease. It aims to see which option works better and is safe, and also to learn how each medicine behaves in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 2 to under 18 years old when you sign consent
- Your child has iron deficiency anemia (low hemoglobin and low iron stores) or is at high risk for it
- Your child has chronic kidney disease, such as dialysis, low kidney filtering (eGFR under 60), or lasting kidney-related urine/tissue problems
- If not on hemodialysis, your child has tried oral iron unsuccessfully, can’t tolerate it, or oral iron isn’t appropriate
- If your child can become pregnant, they must use reliable birth control before starting and during the study
- Your child should not have known allergy to ferumoxytol or iron sucrose or any IV iron
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies IV ferric derisomaltose to treat iron deficiency anemia in children under 18. It is meant for children whose anemia is from a true iron problem and who either cannot tolerate or do not respond to iron taken by mouth, or have certain kidney-related causes.
This study compares two intravenous iron treatments to see if one works as well as the other in people with iron deficiency anemia. It may help improve your iron levels and reduce anemia symptoms.
This trial tests ferumoxytol, an intravenous iron medicine, to treat iron deficiency anemia in children who cannot take or did not respond well to iron by mouth. It aims to improve blood iron levels and anemia symptoms safely.
This trial studies whether taking iron by mouth can improve iron levels and anemia (low red blood cell counts) in children with chronic kidney disease. It may help reduce fatigue and support normal blood-making, by comparing different approaches for children who meet specific iron test results.
This study compares two ways of giving iron to children aged 1 to 5 with moderate iron deficiency anemia. The goal is to see which method works better and is easier for families.
This trial tests an iron infusion called ferric carboxymaltose to treat iron deficiency anemia in children and teens seen in the emergency department. It aims to improve their hemoglobin levels and overall health.
Hear when a new Chronic Kidney Disease; Iron Deficiency Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.